103 related articles for article (PubMed ID: 2185107)
1. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
Sato H; Tsuji A; Hirai K; Kang YS
Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated endocytosis of A14-125I-insulin by the nonfiltering perfused rat kidney.
Sato H; Yoshioka K; Terasaki T; Tsuji A
Biochim Biophys Acta; 1991 Apr; 1073(3):442-50. PubMed ID: 2015267
[TBL] [Abstract][Full Text] [Related]
3. Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers.
Cockram CS; Jones RH; Boroujerdi MA; Sönksen PH
Diabetes; 1984 Aug; 33(8):721-7. PubMed ID: 6378697
[TBL] [Abstract][Full Text] [Related]
4. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
Ryan MP; Peavy DE; Frank BH; Duckworth WC
Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
Peavy DE; Abram JD; Frank BH; Duckworth WC
Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
[TBL] [Abstract][Full Text] [Related]
6. Effect of receptor up-regulation on insulin pharmacokinetics in streptozotocin-treated diabetic rats.
Sato H; Terasaki T; Okumura K; Tsuji A
Pharm Res; 1991 May; 8(5):563-9. PubMed ID: 1866369
[TBL] [Abstract][Full Text] [Related]
7. Early detection of degraded A14-125I-insulin in human fibroblasts by the use of high performance liquid chromatography.
Stentz FB; Harris HL; Kitabchi AE
Diabetes; 1983 May; 32(5):474-7. PubMed ID: 6341131
[TBL] [Abstract][Full Text] [Related]
8. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
[TBL] [Abstract][Full Text] [Related]
10. Metabolic clearance of insulin from the cerebrospinal fluid in the anesthetized rat.
Manin M; Broer Y; Balage M; Rostene W; Grizard J
Peptides; 1990; 11(1):5-12. PubMed ID: 2188232
[TBL] [Abstract][Full Text] [Related]
11. High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease.
Hamel FG; Peavy DE; Ryan MP; Duckworth WC
Endocrinology; 1986 Jan; 118(1):328-33. PubMed ID: 3510119
[TBL] [Abstract][Full Text] [Related]
12. Degradation of insulin by isolated rat renal cortical endosomes.
Fawcett J; Rabkin R
Endocrinology; 1993 Oct; 133(4):1539-47. PubMed ID: 8404592
[TBL] [Abstract][Full Text] [Related]
13. A rapid means of separating A14-125I-insulin from heterogeneously labeled insulin molecules for biologic studies.
Stentz FB; Wright RK; Kitabchi AE
Diabetes; 1982 Dec; 31(12):1128-31. PubMed ID: 6757025
[TBL] [Abstract][Full Text] [Related]
14. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
Semple JW; Ellis J; Delovitch TL
J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861
[TBL] [Abstract][Full Text] [Related]
15. Insulin degradation in vivo: a high-performance liquid chromatographic analysis.
Benzi L; Cecchetti P; Ciccarone AM; Di Cianni G; Iozzi LC; Caricato F; Navalesi R
J Chromatogr; 1990 Dec; 534():37-46. PubMed ID: 2094722
[TBL] [Abstract][Full Text] [Related]
16. Retroendocytosis of insulin in rat adipocytes.
Levy JR; Olefsky JM
Endocrinology; 1986 Aug; 119(2):572-9. PubMed ID: 3525121
[TBL] [Abstract][Full Text] [Related]
17. Insulin degradation into monocytes from normal subjects: a high performance liquid chromatographic analysis.
Benzi L; Marchetti P; Brunetti A; Ciccarone AM; Cecchetti P; Trischitta E; Di Cianni G; Squatrito S; Navalesi R
J Endocrinol Invest; 1988 Apr; 11(4):303-7. PubMed ID: 3045192
[TBL] [Abstract][Full Text] [Related]
18. Separation of biological variant insulin molecules from different species by reversed-phase high-performance liquid chromatography (HPLC).
Kalant D; Crawhall JC; Posner BI
Biochem Med; 1985 Oct; 34(2):230-40. PubMed ID: 3910033
[TBL] [Abstract][Full Text] [Related]
19. A rapid, high-yield method of producing mono-[125I]A14 iodoinsulin.
Lioubin MN; Meier MD; Ginsberg BH
Prep Biochem; 1984; 14(4):303-11. PubMed ID: 6393119
[TBL] [Abstract][Full Text] [Related]
20. A14-125I-monoiodoinsulin purified by high performance liquid chromatography (HPLC): cellular receptor binding properties and long-term stability.
Benzi L; Marchetti P; Cecchetti P; Pezzino V; Gullo D; Masoni A; Navalesi R
J Nucl Med Allied Sci; 1984; 28(4):277-81. PubMed ID: 6399077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
